DUBLIN, May 20, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the "Clinical Immunoassay Analyzer Market in the US 2016-2020" report to their offering.
The clinical immunoassay analyzer market in the US is expected to grow at a CAGR of 6.04% during the period 2016-2020.
Immunoassay analyzers perform biochemical tests to detect antibodies that are specific proteins produced by the body to fight antigens. In clinical laboratories, these analyzers are used to detect a variety of substances, including infectious diseases, cardiac markers, endocrine hormone testing, proteins, and for viral or bacterial determination, from a patient's biological sample such as blood or body fluid.
An emerging trend to not is the use of paper-based electrochemical immunoassay devices. Researchers are working to develop paper-based electrochemical immunoassay devices that can be used for POCT and diagnosis. These tests are inexpensive and can provide results quickly. The paper patterning cost to use it as a substrate can cost as low as $0.01 per device.
According to the report, a key driver of market growth is the rising demand for next-generation immunodiagnostics. Next-generation immunodiagnostic equipment are being designed to address the needs of modern clinical laboratories. These instruments provide high-quality, reliable test results for patients and clinicians. Manufacturers enhance the hardware by innovating technology to improve workflow and turnaround time.
Further, the report states that one challenge that will impact the growth of this market is the high cost of upgrading.
Key vendors:
- Abbott Diagnostics
- Beckman Coulter
- bioMérieux
- Roche Diagnostics
- Siemens Healthcare Diagnostics
Key questions answered in this report:
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
Key Topics Covered:
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Introduction
PART 05: Market landscape
PART 06: Immunoassay clinical analyzers
PART 07: Market segmentation by application
PART 08: Market segmentation by product
PART 09: Market drivers
PART 10: Impact of drivers
PART 11: Market challenges
PART 12: Impact of drivers and challenges
PART 13: Market trends
PART 14: Vendor landscape
PART 15: Key vendor analysis
For more information visit http://www.researchandmarkets.com/research/764df6/clinical
Media Contact:
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Share this article